Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818499) titled 'A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Condition:
Diffuse Large B-Cell Lymphoma
Intervention:
Drug: BL-M08D1
Drug: Rituximab
Drug: Gemcitabine Hydrochloride
Drug: Oxaliplatin
Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride Liposome
Drug: Vincristine Sulfate
Recruitment Status: Not recruiting
Phase: Phase 1/P...